Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 9
1948 4
1949 3
1950 4
1951 8
1952 9
1953 7
1954 13
1955 6
1956 11
1957 3
1958 1
1959 4
1960 8
1961 8
1962 5
1963 8
1964 16
1965 10
1966 11
1967 10
1968 11
1969 8
1970 10
1971 3
1972 8
1973 8
1974 5
1975 7
1976 3
1977 6
1978 12
1979 10
1980 8
1981 9
1982 7
1983 16
1984 7
1985 6
1986 8
1987 8
1988 6
1989 6
1990 9
1991 8
1992 9
1993 10
1994 3
1995 9
1996 8
1997 5
1998 7
1999 10
2000 6
2001 4
2002 6
2003 4
2004 9
2005 8
2006 11
2007 4
2008 12
2009 9
2010 10
2011 10
2012 7
2013 11
2014 6
2015 9
2016 11
2017 5
2018 11
2019 6
2020 10
2021 8
2022 6
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Results by year

Filters applied: . Clear all
Page 1
Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.
Vallera C, Choi LO, Cha CM, Hong RW. Vallera C, et al. Anesthesiol Clin. 2017 Jun;35(2):207-219. doi: 10.1016/j.anclin.2017.01.007. Epub 2017 Mar 30. Anesthesiol Clin. 2017. PMID: 28526143 Review.
Uterine atony is a common cause of primary postpartum hemorrhage, which remains a major cause of pregnancy-related mortality for women worldwide. Oxytocin, methylergonovine, carboprost, and misoprostol are commonly used to restore uterine tone. Oxytocin is the first-line a …
Uterine atony is a common cause of primary postpartum hemorrhage, which remains a major cause of pregnancy-related mortality for women world …
Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone.
Jones AJ, Federspiel JJ, Eke AC. Jones AJ, et al. Am J Obstet Gynecol MFM. 2023 Feb;5(2S):100731. doi: 10.1016/j.ajogmf.2022.100731. Epub 2022 Aug 24. Am J Obstet Gynecol MFM. 2023. PMID: 36028160 Free PMC article. Review.
Pharmacotherapy remains the first-line preventative therapy for postpartum hemorrhage. These therapies may be single (oxytocin, carbetocin, methylergonovine, ergometrine, misoprostol, prostaglandin analogs, or tranexamic acid) or combination therapies, acting in an additiv …
Pharmacotherapy remains the first-line preventative therapy for postpartum hemorrhage. These therapies may be single (oxytocin, carbetocin, …
Methylergonovine maleate and the risk of myocardial ischemia and infarction.
Bateman BT, Huybrechts KF, Hernandez-Diaz S, Liu J, Ecker JL, Avorn J. Bateman BT, et al. Am J Obstet Gynecol. 2013 Nov;209(5):459.e1-459.e13. doi: 10.1016/j.ajog.2013.07.001. Epub 2013 Jul 11. Am J Obstet Gynecol. 2013. PMID: 23850529 Free PMC article.
Propensity score matching was used to address potential confounding. RESULTS: Methylergonovine was administered to 139,617 patients (6.3%). Overall, 6 patients (0.004%) who were exposed to methylergonovine and 52 patients (0.002%) who were not exposed to methyler …
Propensity score matching was used to address potential confounding. RESULTS: Methylergonovine was administered to 139,617 patients ( …
Inadvertent Methylergonovine administration to a newborn.
Wilson K, Santiago R, Preziosi M, Fisher R, Hall AB. Wilson K, et al. Am J Emerg Med. 2021 Jun;44:479.e1-479.e2. doi: 10.1016/j.ajem.2020.10.079. Epub 2020 Nov 5. Am J Emerg Med. 2021. PMID: 33223359
Previous case reports describe the inadvertent administration of methylergonovine to newborns resulting in rare, life-threatening events including neonatal death. To our knowledge, no case reports exist detailing inadvertent methylergonovine administration in the em …
Previous case reports describe the inadvertent administration of methylergonovine to newborns resulting in rare, life-threatening eve …
A randomized controlled trial of methylergonovine prophylaxis after dilation and evacuation abortion.
Kerns JL, Pearlson G, Mengesha B, Harter K, Jackson RA, Drey EA. Kerns JL, et al. Contraception. 2021 Feb;103(2):116-120. doi: 10.1016/j.contraception.2020.10.009. Epub 2020 Oct 17. Contraception. 2021. PMID: 33075332 Clinical Trial.
OBJECTIVE: To evaluate the efficacy of intramuscular methylergonovine maleate as prophylaxis against excessive bleeding when given after dilation and evacuation (D&E) at 20-24 weeks. ...Baseline characteristics were similar between groups. The composite outcome occurre …
OBJECTIVE: To evaluate the efficacy of intramuscular methylergonovine maleate as prophylaxis against excessive bleeding when given af …
Prophylactic Methylergonovine and Oxytocin Compared With Oxytocin Alone in Patients Undergoing Intrapartum Cesarean Birth: A Randomized Controlled Trial.
Masse N, Dexter F, Wong CA. Masse N, et al. Obstet Gynecol. 2022 Aug 1;140(2):181-186. doi: 10.1097/AOG.0000000000004857. Epub 2022 Jul 6. Obstet Gynecol. 2022. PMID: 35852267 Clinical Trial.
RESULTS: From June 2019 through February 2021, 80 patients were randomized to receive methylergonovine plus oxytocin and 80 were randomized to receive to oxytocin alone. Significantly fewer patients who were allocated to the methylergonovine group received additiona …
RESULTS: From June 2019 through February 2021, 80 patients were randomized to receive methylergonovine plus oxytocin and 80 were rand …
Second-line uterotonics and the risk of hemorrhage-related morbidity.
Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed YY, Nelson LM, Bateman BT. Butwick AJ, et al. Am J Obstet Gynecol. 2015 May;212(5):642.e1-7. doi: 10.1016/j.ajog.2015.01.008. Epub 2015 Jan 9. Am J Obstet Gynecol. 2015. PMID: 25582104 Free PMC article.
RESULTS: The study cohort comprised 1335 women; 870 (65.2%) women received methylergonovine and 465 (34.8%) women received carboprost. After accounting for potential confounders, the risk of hemorrhage-related morbidity was higher in the carboprost group than the methyl …
RESULTS: The study cohort comprised 1335 women; 870 (65.2%) women received methylergonovine and 465 (34.8%) women received carboprost …
Inadvertent Methylergonovine Administration to a Neonate.
Corbett BM, O'Connell C, Boutin MA, Fatayerji NI, Sauer CW. Corbett BM, et al. Am J Case Rep. 2016 Oct 21;17:770-773. doi: 10.12659/ajcr.900263. Am J Case Rep. 2016. PMID: 27765939 Free PMC article.
BACKGROUND Methylergonovine is an ergot alkaloid used to treat post-partum hemorrhage secondary to uterine atony. ...CASE REPORT A term infant was inadvertently given 0.1 mg of methylergonovine intramuscularly in the right thigh. The error was only noted when the vi …
BACKGROUND Methylergonovine is an ergot alkaloid used to treat post-partum hemorrhage secondary to uterine atony. ...CASE REPORT A te …
The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of Post-partum Haemorrhage.
Şentürk Ş, Kağıtçı M, Balık G, Arslan H, Kır Şahin F. Şentürk Ş, et al. Basic Clin Pharmacol Toxicol. 2016 May;118(5):338-43. doi: 10.1111/bcpt.12500. Epub 2015 Nov 15. Basic Clin Pharmacol Toxicol. 2016. PMID: 26449959 Free article. Clinical Trial.
The second group did not receive methylergonovine and was administered only with oxytocin infusion in the intra-operative and post-operative periods. ...Results indicated that prophylactic methylergonovine treatment was clearly successful for the patients and no adv …
The second group did not receive methylergonovine and was administered only with oxytocin infusion in the intra-operative and post-op …
577 results